Rivoltini, Licia
Fondazione IRCCS Istituto Nazionale dei Tumori
6 papers on CoChatORCID 0000-0002-2409-6225
Most cited papers
- Verified
Modulation of Microenvironment Acidity Reverses Anergy in Human and Murine Tumor-Infiltrating T Lymphocytes
Calcinotto, A., Filipazzi, P., Grioni, M., Iero, M., De Milito, A., Ricupito, A., Cova, A., Canese, R., Jachetti, E., Rossetti, M., et al. (2012) · Cancer Research
T-cell and B-cell ImmunologyCancer Immunotherapy and Biomarkers
Cited by 640
- Verified
Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation
Huber, V., Camisaschi, C., Berzi, A., Ferro, S., Lugini, L., Triulzi, T., Tuccitto, A., Tagliabue, E., Castelli, C., & Rivoltini, L. (2017) · Seminars in Cancer Biology
Cancer, Hypoxia, and MetabolismCancer Immunotherapy and Biomarkers
Cited by 595
- Verified
Human Tumor-Released Microvesicles Promote the Differentiation of Myeloid Cells with Transforming Growth Factor-β–Mediated Suppressive Activity on T Lymphocytes
Valenti, R., Huber, V., Filipazzi, P., Pilla, L., Sovena, G., Villa, A., Corbelli, A., Fais, S., Parmiani, G., & Rivoltini, L. (2006) · Cancer Research
Immune cells in cancerExtracellular vesicles in disease
Cited by 493
- Verified
Effect of Proton Pump Inhibitor Pretreatment on Resistance of Solid Tumors to Cytotoxic Drugs
Luciani, F., Spada, M., De Milito, A., Molinari, A., Rivoltini, L., Montinaro, A., Marra, M., Lugini, L., Logozzi, M., Lozupone, F., et al. (2004) · JNCI Journal of the National Cancer Institute
Cancer, Hypoxia, and MetabolismDrug Transport and Resistance Mechanisms
Cited by 435
- Verified
LAG-3 Expression Defines a Subset of CD4+CD25highFoxp3+ Regulatory T Cells That Are Expanded at Tumor Sites
Camisaschi, C., Casati, C., Rini, F., Perego, M., De Filippo, A., Triebel, F., Parmiani, G., Belli, F., Rivoltini, L., & Castelli, C. (2010) · The Journal of Immunology
T-cell and B-cell ImmunologyCancer Immunotherapy and Biomarkers
Cited by 350
- Verified
miR-146a-5p impairs melanoma resistance to kinase inhibitors by targeting COX2 and regulating NFkB-mediated inflammatory mediators
Vergani, E., Dugo, M., Cossa, M., Frigerio, S., Di Guardo, L., Gallino, G., Mattavelli, I., Vergani, B., Lalli, L., Tamborini, E., et al. (2020) · Cell Communication and Signaling
Melanoma and MAPK PathwaysMicroRNA in disease regulation
Cited by 39
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free